Steve Basta

Biography

 In October 2011 Mr. Basta was appointed CEO of AlterG, a rehabilitation and fitness products company providing revolutionary technology to improve mobility, including the AlterG Anti-Gravity Treadmill and the AlterG Bionic Leg. Before joining AlterG, he led several emerging biopharmaceutical and medical device companies. From 2002 through 2010, he was CEO of BioForm Medical, Inc., leading the company through global commercialization of advanced aesthetics technologies; including an initial public offering as well as an acquisition by Merz, a German pharmaceutical company. Following the acquisition by Merz, he served as the global business unit leader for Merz Aesthetics, Inc. from 2010 through 2011. Prior to this he was President and CEO of Gliatech, Inc., VP Business Development and Chief Financial Officer of Creative BioMolecules, Inc., and Executive Director of Product Development for The Immune Response Corporation. Mr. Basta began his career in investment banking with Dillon, Read and Co. Inc. Mr. Basta holds a BA in BioMedical Engineering from The Johns Hopkins University and received his Master of Management degree from the Kellogg Graduate School of Business at Northwestern University.

Research Interest

  BioMedical Engineering Products